111 related articles for article (PubMed ID: 37991523)
21. Does antiretroviral therapy change the relationship between body composition and muscle strength in children and adolescents diagnosed with HIV?
Martins PC; Alves Junior CAS; Lima LRA; Petroski EL; Silva DAS
HIV Res Clin Pract; 2022 Feb; 23(1):22-27. PubMed ID: 35191357
[No Abstract] [Full Text] [Related]
22. Growth improvement following antiretroviral therapy initiation in children with perinatally-acquired HIV diagnosed in older childhood in Zimbabwe: a prospective cohort study.
Simms V; McHugh G; Dauya E; Bandason T; Mujuru H; Nathoo K; Munyati S; Weiss HA; Ferrand RA
BMC Pediatr; 2022 Jul; 22(1):446. PubMed ID: 35879693
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
Han WM; Wattanachanya L; Apornpong T; Jantrapakde J; Avihingsanon A; Kerr SJ; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Ramautarsing R; Phanuphak N; Sunthornyothin S; Ruxrungtham K; Phanuphak P;
PLoS One; 2020; 15(3):e0230368. PubMed ID: 32210458
[TBL] [Abstract][Full Text] [Related]
24. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
Newell ML; Borja MC; Peckham C;
Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
[TBL] [Abstract][Full Text] [Related]
25. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
[TBL] [Abstract][Full Text] [Related]
26. [To evaluate the changes in body composition in male human immunodeficiency virus-related lipodystrophy after different treatment regimens by dual-energy X-ray absorptiometry].
Zhou X; Yu W; Li T; Guo F; Lin Q; Shao H; Tian J; Xu Y; Sun P
Zhonghua Nei Ke Za Zhi; 2014 Aug; 53(8):622-5. PubMed ID: 25376824
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density in children and adolescents with perinatal HIV infection.
DiMeglio LA; Wang J; Siberry GK; Miller TL; Geffner ME; Hazra R; Borkowsky W; Chen JS; Dooley L; Patel K; van Dyke RB; Fielding RA; Gurmu Y; Jacobson DL;
AIDS; 2013 Jan; 27(2):211-20. PubMed ID: 23032412
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
[TBL] [Abstract][Full Text] [Related]
29. Associations of muscle force, power, cross-sectional muscle area and bone geometry in older UK men.
Zengin A; Pye SR; Cook MJ; Adams JE; Rawer R; Wu FCW; O'Neill TW; Ward KA
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):598-606. PubMed ID: 28474432
[TBL] [Abstract][Full Text] [Related]
30. Cardiopulmonary dysfunction in perinatally HIV-infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort.
Githinji LN; Mahtab S; Zühlke L; Lawrenson J; Myer L; Gray D; Zar H
J Int AIDS Soc; 2019 Jul; 22(7):e25340. PubMed ID: 31291058
[TBL] [Abstract][Full Text] [Related]
31. Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.
Güerri-Fernández R; Lerma-Chippirraz E; Fernandez Marron A; García-Giralt N; Villar-García J; Soldado-Folgado J; González-Mena A; Trenchs-Rodríguez M; Guelar A; Díez-Pérez A; Brown TT; Knobel H
AIDS; 2018 Apr; 32(7):913-920. PubMed ID: 29424785
[TBL] [Abstract][Full Text] [Related]
32. The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study.
Alvarez E; Campbell L; Tinago W; Garcia-Leon A; Walsh I; Brady JJ; Burling K; Noe S; Neuville MF; Jouret F; Jamshidian F; Graham H; Rhee M; Mallon PW; Post FA
Antivir Ther; 2022 Aug; 27(4):13596535221094898. PubMed ID: 36000318
[TBL] [Abstract][Full Text] [Related]
33. Lean mass and lower limb muscle function in relation to hip strength, geometry and fracture risk indices in community-dwelling older women.
Elhakeem A; Hartley A; Luo Y; Goertzen AL; Hannam K; Clark EM; Leslie WD; Tobias JH
Osteoporos Int; 2019 Jan; 30(1):211-220. PubMed ID: 30552442
[TBL] [Abstract][Full Text] [Related]
34. Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients.
Hamzah L; Samarawickrama A; Campbell L; Pope M; Burling K; Fisher M; Gilleece Y; Walker-Bone K; Post FA
AIDS; 2015 Sep; 29(14):1785-1792. PubMed ID: 26372384
[TBL] [Abstract][Full Text] [Related]
35. The Prevalence and Associated Factors of Reduced Bone Mineral Density (BMD) Among Men with Suppressed Viral Load Taking Antiretroviral Therapy.
Ozcan SN; Sevgi DY; Oncul A; Gunduz A; Pehlivan O; Terlemez R; Kuran B; Dokmetas I
Curr HIV Res; 2022; 20(1):74-81. PubMed ID: 34856908
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Lean Mass, Muscle Strength and Power, and Skeletal Size, Density and Strength in Older Men.
Chalhoub D; Boudreau R; Greenspan S; Newman AB; Zmuda J; Frank-Wilson AW; Nagaraj N; Hoffman AR; Lane NE; Stefanick ML; Barrett-Connor E; Dam T; Cawthon PM; Orwoll ES; Cauley JA;
J Bone Miner Res; 2018 Sep; 33(9):1612-1621. PubMed ID: 29701926
[TBL] [Abstract][Full Text] [Related]
37. A 10-year follow-up of bone mineral density in HIV-infected youths receiving tenofovir disoproxil fumarate.
Giacomet V; Maruca K; Ambrosi A; Zuccotti GV; Mora S
Int J Antimicrob Agents; 2017 Sep; 50(3):365-370. PubMed ID: 28689877
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.
Bedimo R; Cutrell J; Zhang S; Drechsler H; Gao A; Brown G; Farukhi I; Castanon R; Tebas P; Maalouf NM
AIDS; 2016 Feb; 30(4):601-8. PubMed ID: 26558726
[TBL] [Abstract][Full Text] [Related]
39. Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.
Mirembe BG; Kelly CW; Mgodi N; Greenspan S; Dai JY; Mayo A; Piper J; Akello CA; Kiweewa FM; Magure T; Nakabiito C; Marrazzo JM; Chirenje ZM; Riddler SA;
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):287-94. PubMed ID: 26866954
[TBL] [Abstract][Full Text] [Related]
40. Muscle mass, strength, bone mineral density and vascular function in middle-aged people living with HIV vs. age-matched and older controls.
Lopes KG; Farinatti P; Lopes GO; Paz GA; Bottino DA; Oliveira RB; Bouskela E; Borges JP
Braz J Infect Dis; 2021; 25(6):101654. PubMed ID: 34826379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
